Key Insights

Highlights

Success Rate

84% trial completion

Published Results

23 trials with published results (12%)

Research Maturity

109 completed trials (55% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

10.1%

20 terminated out of 199 trials

Success Rate

84.5%

-2.0% vs benchmark

Late-Stage Pipeline

19%

38 trials in Phase 3/4

Results Transparency

21%

23 of 109 completed with results

Key Signals

23 with results84% success20 terminated

Data Visualizations

Phase Distribution

140Total
Not Applicable (70)
Early P 1 (1)
P 1 (20)
P 2 (11)
P 3 (12)
P 4 (26)

Trial Status

Completed109
Unknown31
Recruiting23
Terminated20
Withdrawn8
Active Not Recruiting5

Trial Success Rate

84.5%

Benchmark: 86.5%

Based on 109 completed trials

Clinical Trials (199)

Showing 20 of 20 trials
NCT07556289Phase 2Recruiting

Transoral Incisional Fundoplication (TIF) for Patients Suffering From Gastroesophageal Reflux Disease in an Asian Population

NCT06955520Not ApplicableRecruitingPrimary

Vonaprazan Versus Esomeprazole for Healing of LA Grade B or Higher Esophagitis After POEM

NCT07544433Not ApplicableRecruitingPrimary

Diaphragmatic Training on GERD

NCT07310927Phase 2CompletedPrimary

Alginate vs Sucralfate for GERD Symptomatic Relief

NCT07506746Recruiting

PRospective Registry of Esophageal Motility

NCT04699591Not ApplicableRecruitingPrimary

Compassionate Use of Domperidone for Refractory Gastroparesis

NCT06953986Not ApplicableRecruitingPrimary

A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks

NCT07421011Phase 1Recruiting

Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers.

NCT05696184Not ApplicableRecruitingPrimary

Mechanisms Preventing Pharyngeal Reflux

NCT01799967Active Not Recruiting

Minimally Invasive Surgery of the Gastro-esophageal Junction

NCT04360252Not ApplicableActive Not Recruiting

Gracie Diet for Gastroesophageal Reflux Disease

NCT07268820Phase 4RecruitingPrimary

Heartburn, Gastroesophageal Reflux Disease

NCT03705416Active Not RecruitingPrimary

Long Term Outcomes of Bariatric Patients Treated With Surgery or Endoscopy

NCT05874726Active Not Recruiting

Biological Sample Repository for Gastrointestinal Disorders

NCT05042063Completed

Acoustic Cough Monitoring for the Management of Patients With Known Respiratory Disease

NCT07227506RecruitingPrimary

Utility of Mucosal Impedance Device in Chronic Esophageal Disorders:

NCT05974722Not ApplicableRecruiting

Mesh Vs Pledgets for Repair of Paraesophageal Hernia

NCT04626232Not ApplicableTerminated

Comparison of the Sleeve Gastrectomy Technique With a Nissen Fundoplication Added to the Conventional Sleeve Gastrectomy Technique in Morbidly Obese Patients

NCT04795934Not ApplicableActive Not RecruitingPrimary

Multicenter Single-Blind RCT of CTIF Versus LNF For Treatment of GERD in Patients Requiring Hiatal Hernia Repair

NCT07125638Completed

Long-term Follow-up After OAGB

Scroll to load more

Research Network

Activity Timeline